"Higher expression of LOX is associated with invasion and is an independent predictor of poor prognosis in patients with early stage lung adenocarcinoma"
http://www.ncbi.nlm.nih.gov/pubmed/21117164
Cancer. 2010 Nov 29. [Epub ahead of print]
Lysyl oxidase: A lung adenocarcinoma biomarker of invasion and survival.
Wilgus ML, Borczuk AC, Stoopler M, Ginsburg M, Gorenstein L, Sonett JR, Powell CA.
Division of Pulmonary, Allergy and Critical Care, Columbia University Medical Center, New York, New York.
No comments:
Post a Comment